The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)
Abstract
An updated World Health Organization (WHO) classification of female genital tumours was published in autumn 2020. We discuss the major new additions to and changes from the prior 2014 classification with a discussion of the reasons underlying these. A feature of the new classification is the greater emphasis on key molecular events with integration of morphological and molecular features. Most of the major changes from the prior classification pertain to uterine (corpus and cervix) and vulval tumours, but changes in all organs are covered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784 · cited 5×
“In contrast to tubo-ovarian HGSC, however, some p53abn endometrial carcinomas have recurrent mutations in PIK3CA, FBXW7, and PPP2R1A46; they are less likely to have mutations in BRCA1 or BRCA2 than is tubo-ovarian HGSC.46,67 HER2 amplification occurs in ~20% of this molecular subtype, and a proportion have homologous…”
BackgroundInfluentialOvarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814 · cited 1×
“In the 4th edition, it was emphasised that the five main ovarian carcinoma histotypes (high-grade serous, low-grade serous, endometrioid, clear cell, and mucinous) differ with respect to risk factors, genetic events during oncogenesis, precursor lesions, immunophenotype, patterns of spread, response to chemotherapy, a…”
BackgroundSelf-citationEndometrioid adenocarcinoma arising from endometriosis of the uterine cervix: A case report
Park, H. M., Lee, S. S., Eom, D. W., Kang, G. H., Yi, S. W., & Sohn, W. S. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.4.767 · Cited by 34
Cited by
Global epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00881-3 · Cited by 571
Metadata
- Authors
- McCluggage, W. G., Singh, N., & Gilks, C. B.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2022-02-20
- Volume
- 80
- Issue
- 5
- Pages
- 762-778
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W4205815974
- Cited by
- 184
- References
- 4
- FWCI
- 21.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). https://app.cochat.ai/papers/10.1111/his.14609
- The paper
- McCluggage, W. G., Singh, N., & Gilks, C. B. (2022). Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology. https://doi.org/10.1111/his.14609
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.